Psychedelic Medicine Through the Lens of Neuroscience
.
Psychedelic Medicine Through the Lens of Neuroscience
Set and setting are a foundational framework in psychedelic medicine. Set refers to the internal state a person brings into treatment, including mood, expectations, fears, intentions, readiness, trauma history, stress level, and sense of trust. Setting refers to the therapeutic relationship, external environment, including the room, music, lighting.
This article explores why these factors matter through the lens of neuroscience. Treatments such as ketamine therapy, Spravato treatment, Transcranial Magnetic Stimulation (neuromodulation), psychedelic-assisted therapy, and psychotherapy can influence arousal, emotional processing, attention, memory, neuroplasticity, and learning. These treatments do not happen in isolation. They happen in a person’s nervous system, in a room, in a relationship, and in the context of that person’s history, fears, hopes, expectations, and capacity for trust.
Set and setting do not guarantee a particular outcome, but they are clinically essential when working with modalities that alter brain neuro-circuitry. They can influence safety, tolerability, emotional openness, and the potential of new learning.
Safety, Threat Detection, and the Nervous System
During treatments that alter state or increase emotional access, sensations, memories, emotions, and relational cues may feel more vivid or meaningful. For some people, this can create openness. For others, especially those with trauma histories, it may activate fear, shame, control, or dissociation.
A poorly held setting may increase hypervigilance, panic, avoidance, mistrust, or post-session destabilization. A supportive setting can help the nervous system register enough safety to remain engaged with what is arising.
The goal is not to make the experience comfortable at all times. Meaningful treatment can involve discomfort, grief, uncertainty, or emotional intensity. The goal is to create enough safety and support that difficult material can be approached without overwhelming the person’s capacity to stay present.
Why Context Shapes Meaning
The brain does not simply record experiences. It interprets them.
Lighting, sound, privacy, clinician presence, and preparation can all influence whether an experience is encoded as threatening, confusing, reparative, meaningful, or useful. This is one reason the therapeutic container matters. The environment does not replace the treatment, but it can shape how the treatment is experienced.
This is especially relevant when working with treatments that affect salience — the process by which the brain marks something as important. In depression, very little may feel rewarding, meaningful, or possible. In anxiety, threat cues may become overly important. In trauma, ordinary sensations or relational cues may be interpreted as danger. In OCD, intrusive thoughts can feel urgent or morally loaded. In shame, self-critical narratives can feel deeply true.
When someone is in a more emotionally open or flexible state, the surrounding context may help shape what becomes most salient.
Neuroplasticity Is Opportunity, Not Outcome
Many modern psychiatric treatments are discussed through the language of neuroplasticity. Ketamine and Spravato/esketamine involve glutamate signaling, AMPA receptor activity, BDNF-related pathways, synaptic plasticity, and changes in functional connectivity, although the full mechanism is still being studied. Classic psychedelics, such as psilocybin, LSD, and ayahuasca, as well as empathogens such as MDMA, appear to work through other novel mechanisms that can catalyze shifts in internal states, emotional processing, neuroplasticity, and the way different areas of the brain communicate. TMS and other neuromodulation approaches may influence cortical excitability and network-level plasticity.
But neuroplasticity does not automatically mean healing. A more flexible or plastic state may create an opening for new learning, but what is learned still matters.
This is one reason preparation and integration are so important. If a treatment creates a window of flexibility, the therapeutic environment can help guide that flexibility toward safety, agency, emotional processing, and behavior change.
Carhart-Harris’s REBUS model, or “Relaxed Beliefs Under Psychedelics,” offers one helpful way to think about this in psychedelic science. The model proposes that psychedelics may temporarily loosen the rigidity of high-level beliefs and predictions, allowing more bottom-up emotional, sensory, and autobiographical material to emerge. (PubMed)
While this model applies specifically to psychedelics, it offers a broader clinical reminder: when old beliefs become more flexible, context matters.
For example, deeply held predictions such as “I am not safe,” “I cannot tolerate this feeling,” “I am broken,” or “nothing can change” may become available for updating. But activation alone is not enough. For healing, the person needs a new experience alongside the old pattern.
Preparation: Creating Orientation and Agency
Preparation helps reduce uncertainty and supports a person’s sense of agency. It can include psychoeducation, discussion of expected sensations, intention setting, safety planning, consent, boundaries, music selection, and logistics for the day of treatment.
The purpose of preparation is not to control the experience. It is to help the person feel oriented enough to move through the experience with support.
Preparation may also help a person understand that unusual sensations, emotional shifts, imagery, or changes in perception can be part of the treatment experience. This can reduce fear and help the nervous system interpret the experience as tolerable rather than dangerous.
The Treatment Session: Creating a Safe Environment
While using substances that alter states of consciousness, people become more sensitive to internal and external cues. A intentional space, music, and an attuned clinician presence help reduce unnecessary threat load.
The clinician’s approac matters. When the provider is calm, grounded, non-intrusive, trauma-informed, and clear with boundaries, a safe space can emerge for the person’s process to unfold. The role of the therapist is not to force insight or impose meaning. It is to support safety, orientation, and adaptive learning.
This is also why boundaries are so important. Altered or emotionally vulnerable states require careful attention to consent, touch, pacing, privacy, and relational clarity.
Integration: Turning Experience Into Change
Integration is the process of helping an acute treatment experience become connected to daily life. Without integration, a session may feel powerful or meaningful but not necessarily become functionally transformative.
A helpful sequence is:
Preparation → Experience → Regulation → Meaning → Behavior Change
First, the nervous system settles. Then the person can begin to reflect on what themes emerged, what tightly held narratives may have softened, what shifted, what new perspectives became available, and what small behaviors might support continued change.
Helpful integration questions might include:
“What pattern felt less fixed after the session?”
“What does your nervous system need in this moment?”
“What new tools, coping strategies, or boundaries might support this insight in daily life?”
“Where can these new insights be practiced?”
Integration should be practical, not only reflective. It may include therapy follow-up, journaling, lifestyle changes, somatic techniques, coping mechanisms, relational repair, boundary-setting, or small behavior changes that reinforce new learning.
Memory, Emotional Learning, and New Experience
Many symptoms can be understood as learned predictions held in the body and nervous system:
“I am not safe.”
“I will be abandoned.”
“I cannot tolerate this feeling.”
“My body is dangerous.”
“I have to stay in control.”
“Nothing can change.”
A treatment session may activate old emotional material, but activation by itself is not always therapeutic. For emotional learning to shift, the person often needs a new experience at the same time. Research on memory reconsolidation suggests that previously learned emotional responses may become more modifiable when reactivated under conditions that allow updating. (PMC)
In clinical terms, this might look like:
Old learning: “This feeling will overwhelm me.”
New experience: “I can feel this while supported.”
Updated learning: “This feeling is painful, but not dangerous.”Old learning: “No one will be there for me.”
New experience: “Someone is present and attuned.”
Updated learning: “Support can be safe.”Old learning: “Nothing can change.”
New experience: “A new state is possible.”
Updated learning: “My current pattern may not be permanent.”
The therapist, room, music, pacing, preparation, and integration all help provide the new context in which old learning can be revisited without simply being repeated.
A Note for Clinicians New to Psychedelic Medicine
Set and setting do not require vague claims about “vibes” or atmosphere. A more grounded way to say this is:
Treatments that shift state can change how people process emotion, attention, memory, and meaning. Context shapes state-dependent learning. Therefore, context is clinically relevant.
Even if future research clarifies that some aspects of set and setting affect subjective experience more than long-term outcomes, they remain important for safety and tolerability. A thoughtful setting may reduce panic, shame, re-traumatization, boundary confusion, and post-session destabilization.
Final Thought
Set and setting are not decorative parts of treatment. They are part of the clinical container.
When the nervous system is more sensitive to experience, context matters more. Preparation, therapeutic presence, supportive environment, and integration help create the conditions in which treatment can become not only biologically active, but personally meaningful.
The goal is not to overstate what set and setting can do. The goal is to recognize that healing is shaped by biology, relationship, environment, readiness, safety, and the lived experience of the person receiving care.
References
Carhart-Harris, R. L., & Friston, K. J. (2019). REBUS and the anarchic brain: Toward a unified model of the brain action of psychedelics. Pharmacological Reviews, 71(3), 316–344.
Carhart-Harris, R. L., Roseman, L., Haijen, E., Erritzoe, D., Watts, R., Branchi, I., & Kaelen, M. (2018). Psychedelics and the essential importance of context. Journal of Psychopharmacology, 32(7), 725–731.
Beckers, T., & Kindt, M. (2017). Memory reconsolidation interference as an emerging treatment for emotional disorders: Strengths, limitations, challenges, and opportunities. Annual Review of Clinical Psychology, 13, 99–121.
Kang, M. J. Y., et al. (2022). Ketamine and molecular neuroplasticity: A systematic review. Frontiers in Psychiatry, 13, 860882.
Pardossi, S., et al. (2024). Variations in BDNF and their role in the neurotrophic mechanisms of ketamine and esketamine. International Journal of Molecular Sciences, 25(24), 13658.
